Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile-Reference-Cited by-同舟云学术

Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile

Published:2016-05-23 Issue:5 Volume:16 Page:415-428
ISSN:1568-0096
Container-title:Current Cancer Drug Targets
language:en
Short-container-title:CCDT

Author:

Gonzzlez-Martin Antonio,Alba Emilio,Ciruelos Eva,Cortes Javier,Llombart Antonio,Lluch Ana,Andres Raquel,Alvarez Isabel,Manuel Aramendia Jose,Ayala de la Pena Francisco,Barnadas Agusti,Batista Norberto,Calvo Lourdes,Galve Elena,Garcia-Palomo Andres,Angel Garcia-Saenz Jose,de la Haba Juan,Lopez Rafael,Lopez-Vivanco Guillermo,Martinez-Janez Noelia,Martinez de Duenas Eduardo,Plazaola Arrate,Rodriguez-Lescure Alvaro,Ruiz Manuel,Sanchez-Rovira Pedro,Santaballa Ana,Angel Segui Miguel,Tusquets Ignasi,Zamora Pilar,Martin Miguel

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Drug Discovery,Pharmacology,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. XRCC2 knockdown effectively sensitizes esophageal cancer to albumin-paclitaxel in vitro and in vivo;Biochemical Genetics;2024-07-24

2. Effects of Ultrasound Contrast Agent-Encapsulated Paclitaxel Extract on the Proliferation and Invasion Ability of Hepatocellular Carcinoma Cells;Science of Advanced Materials;2023-11-01

3. Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC);Cancers;2021-09-23

4. Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue;International Journal of Molecular Sciences;2021-04-28

5. Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer;Journal of Oncology;2020-11-28